Nektar Therapeutics (Nasdaq: NKTR) today announced new data from the ongoing REZOLVE-AD Phase 2b study of rezpegaldesleukin, ...

July 24, 2025 – The FDA has approved a new treatment as the first and only skin cream for a specific type of hand eczema that affects about 1 in every 10 people globally. The cream, sold under the ...

Exercising with eczema needs care. Sweat, friction, and heat can trigger flare-ups. Opt for breathable fabrics, short ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Free webinar—Filing for Social Security: Sometimes Timing Is ...

Amlitelimab, dosed every four weeks or every 12 weeks, demonstrated statistically significant and clinically meaningful efficacy in skin clearance and disease severity compared to placebo at week 24, ...

UW Health's Dr. Jeff Pothof discusses a new blood pressure medication that has shown promise in trials, as well as other health headlines. New Release: Farm, merge, grow and expand your land in this ...

Stress during pregnancy, perhaps around the 6-to-8-month mark especially, may prime certain immune cells in a fetus’s skin to overreact, leading to eczema. Immune cells called mast cells in the skin ...

On Tuesday, pharmaceutical company Eli Lilly said its new oral GLP-1 drug was shown to be effective at lowering weight and A1C, a key blood sugar marker. Despite the oral drug being a little less ...

A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem, Tracy Diamond and colleagues from Merck & Co., Inc., Rahway, NJ, USA, ...

Oral therapies are projected to account for 25% of the anti-obesity medication market by 2030—but first returns have largely disappointed. This month, shares of both Eli Lilly and Viking Therapeutics ...

Around 25% of hay fever sufferers in the UK are allergic to birch tree pollen. This means that for a good chunk of the population, the arrival of spring and summer means sneezing, itchy eyes, blocked ...